The SPIN program is particularly interested in supporting innovative research on immunoglobulin therapies in neurology.
Proposals may include, but are not limited to:
- Efficacy
- Mechanism of action
- Safety and tolerability
- Quality of life
- Pharmacoeconomics
The SPIN Award Program offers €50,000 to the applicant whose proposal best matches the program's objectives, as assessed by an independent Review Committee. The SPIN Award aims to:
- Advance scientific understanding of immunoglobulins in neurological diseases.
- Explore novel therapeutic applications of immunoglobulins in neurological disorders.
- Promote the development of innovative immunoglobulin-based treatment strategies aimed at improving patient outcomes.